Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques

August 9, 2022 updated by: Vinicius Magno da Rocha, Gaffree & Guinle Universitary Hospital

Cutibacterium Acnes Colonization on Intervertebral Discs of Patients With Low Back Pain: Protocol for an Analytical Study With Microbiological, Phenotypic, Genotypic and Multiomics Techniques

The study aims to identify metabolites present in intervertebral discs colonized by C. acnes from patients with low back pain and degenerative disc disease, correlating them with their clinical, radiological and demographic profiles.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Rio de Janeiro, Brazil, 20270-004
        • Recruiting
        • Hospital Universitario Gaffree e Guinle
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • low back pain lasting longer than 3 months;
  • MRI findings of degenerative lumbar discopathy (DDL) performed less than 6 months after inclusion in the study;
  • indication for open surgical treatment, with isolated microdiscectomy or associated with lumbar arthrodesis;
  • failure of conservative treatment for at least 6 weeks and/or progressive neurological deficit

Exclusion Criteria:

  • History of open lumbar spine surgery at any stage of life;
  • presence of chemotherapy or pulse therapy with corticoids;
  • patients with immune deficiency;
  • patients undergoing previous intradiscal therapies (nucleotomy or discography);
  • patients undergoing previous endoscopic surgery;
  • patients with a history of previous spinal infection treated with antibiotics in the 6 months prior to inclusion in the study;
  • use of antibiotics in the 2 months prior to the surgical procedure

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Factorial Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: surgical treatment
Lumbar Spinal Fusion Surgery
During surgery will be collected five disc fragments and five fragments of muscle-ligament tissue adjacent to the collected disc.
Experimental: Bacterial culture

Cutibacterium acnes culture in two different atmosphere:

  • Carbon dioxide (CO2) from 5% up to 10%
  • CO2 10%, H2 10% and N2 80%
Samples will be seeded on blood agar and anaerobic blood agar plates. After sowing in solid media, the swab will be inoculated in thioglycolate medium, where it will remain for 14 days
Experimental: Phenotypic and genotypic characterization
Mass spectrometry and (Polimerase Chain Reaction) PCR

The phenotypic identification of the species will be carried out through mass spectrometry, with the MALDI-TOF equipment.

PCR analyzes performed in two phases, the first to confirm the presence of bacteria (target and non-target) using primers capable of amplifying eubacteria ribosomal deoxyribonucleic acid (rDNA) 16s and the second directed to confirm C. acnes through specific rDNA 16s primers.

Experimental: Multiomics analysis
  • Genome sequencing
  • Proteomics
  • Metabolomics
Whole Genome Sequencing, proteomics and metabolomics analysis

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of C. acnes on intervertebral disc
Time Frame: Up to 5 months
Incidence of C. acnes on intervertebral disc in patients with chronic low back pain and DDL.
Up to 5 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Actual)

August 1, 2022

Study Completion (Anticipated)

October 1, 2022

Study Registration Dates

First Submitted

September 28, 2021

First Submitted That Met QC Criteria

October 11, 2021

First Posted (Actual)

October 22, 2021

Study Record Updates

Last Update Posted (Actual)

August 10, 2022

Last Update Submitted That Met QC Criteria

August 9, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Degenerative Disc Disease

Clinical Trials on Lumbar Spinal Fusion Surgery

3
Subscribe